Tirzepatide
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Eli Lilly · Phase 2 · Active, not recruiting · Enrollment 414
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.